Pilot Study of Reduced Venetoclax Exposure
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Azacitidine
Related studies linked through entity extraction aliases.
Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE2
Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients
- Status
- RECRUITING
- Phase
- PHASE3
MRD-positive AML Clinical Study
- Status
- RECRUITING
- Phase
- NA
A Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard Continuous Venetoclax Exposure Combined With Azacitidine in Treatment Naïve Subjects With Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India
- Status
- RECRUITING
- Phase
- PHASE4
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
- Status
- RECRUITING
- Phase
- PHASE2
Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
- Status
- RECRUITING
- Phase
- PHASE2
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE1
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
- Status
- RECRUITING
- Phase
- PHASE1
Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL
- Status
- RECRUITING
- Phase
- PHASE2